Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS)

Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a prevalent neurologic autoimmune disorder affecting two million people worldwide. Symptoms include gait abnormalities, perception and sensory losses, cranial nerve pathologies, pain, cognitive dysfunction, and emotional aberrancies. Traditional therapy includes corticoste...

Full description

Bibliographic Details
Main Authors: Amnon A. Berger, Emily R. Sottosanti, Ariel Winnick, Jonathan Izygon, Kevin Berardino, Elyse M. Cornett, Alan D. Kaye, Giustino Varrassi, Omar Viswanath, Ivan Urits
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Neurology International
Subjects:
autoimmune
corticosteroids
disease-modifying agents
CNS plaques
disability
Online Access:https://www.mdpi.com/2035-8377/13/2/22

Internet

https://www.mdpi.com/2035-8377/13/2/22

Similar Items